Micron Biomedical CEO, Steven Damon, speaks at the Bio International Convention on a panel moderated by Endpoints reporter, Max Bayer, about Who are the Biotech Underdogs and What Will It Take for Them to Succeed. During the conversation, Steven discussed overcoming challenges in public perception to advnce technology that is addressing preference, access gaps and other challenges.
